Inactive

CDER is seeking access to well-curated (manually and automatically tagged, sorted and organized based on biomarker types and use) knowledge (scientific publications and reports, clinical trials, regul... CDER is seeking access to well-curated (manually and automatically tagged, sorted and organized based on biomarker types and use) knowledge (scientific publications and reports, clinical trials, regulatory submissions to the global health authorities) database and search/analytics capabilities to assist FDA in reviewing and making an informed data-driven decision about the adequacy of the submitted data to support Drug Development Tool qualification. Licensing access to a suite of biomarker-related contents and analytical tools will be used to support and speed up the evaluation and recommendations for biomarker DDT submissions. The Government intends to issue a firm fixed-price purchase order as result of this solicitation. Please see the attached RFQ for compete requirement details and quotation submission instructions.